Squarepoint
OGN icon

Squarepoint’s Organon & Co OGN Stock Holding History

Squarepoint’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.28M Sell
390,232
-441,192
-53% -$5.28M 0.01% 1562
2026
Q1 		$4.98M Buy
831,424
+470,492
+130% +$3.54M 0.01% 1508
2025
Q4 		$2.59M Buy
360,932
+85,256
+31% +$674K ﹤0.01% 1877
2025
Q3 		$2.94M Buy
275,676
+159,174
+137% +$1.56M ﹤0.01% 1801
2025
Q2 		$1.13M Buy
+116,502
New +$1.2M ﹤0.01% 2562
2025
Q1 		– Sell
-135,332
Closed -$2.02M – 5170
2024
Q4 		$2.02M Sell
135,332
-128,734
-49% -$2.1M ﹤0.01% 2401
2024
Q3 		$5.05M Buy
264,066
+231,658
+715% +$4.8M 0.01% 1417
2024
Q2 		$671K Buy
+32,408
New +$644K ﹤0.01% 2857
2024
Q1 		– Sell
-1,444,318
Closed -$20.8M – 4430
2023
Q4 		$20.8M Buy
1,444,318
+1,418,464
+5,486% +$19.3M 0.04% 553
2023
Q3 		$449K Sell
25,854
-462,890
-95% -$9.65M ﹤0.01% 2871
2023
Q2 		$10.2M Buy
488,744
+446,009
+1,044% +$9.69M 0.03% 665
2023
Q1 		$1.01M Sell
42,735
-285,689
-87% -$7.67M ﹤0.01% 1891
2022
Q4 		$9.17M Sell
328,424
-139,977
-30% -$3.58M 0.04% 535
2022
Q3 		$11M Buy
468,401
+321,698
+219% +$9.71M 0.06% 398
2022
Q2 		$4.95M Buy
146,703
+126,948
+643% +$4.45M 0.03% 686
2022
Q1 		$690K Sell
19,755
-78,243
-80% -$2.68M ﹤0.01% 1816
2021
Q4 		$2.98M Buy
97,998
+30,671
+46% +$999K 0.01% 1032
2021
Q3 		$2.21M Buy
67,327
+46,991
+231% +$1.5M 0.01% 1158
2021
Q2 		$615K Buy
+20,336
New +$669K ﹤0.01% 1991

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Squarepoint's OGN Position: Q2 2026 in Review

Squarepoint reduced its Organon & Co (OGN) stake by 53% in Q2 2026, selling an estimated $5.28M and leaving 390,232 shares worth $5.28M. The position accounts for 0.01% of the portfolio, ranked #1562.

Squarepoint first reported a position in OGN in Q2 2021 and has held it in 19 quarters since. The position peaked at $20.8M in Q4 2023. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Squarepoint held 390,232 shares of Organon & Co worth $5.28M as of Q2 2026.
  • Squarepoint sold 441,192 Organon & Co shares in Q2 2026, an estimated $5.28M.
  • Organon & Co made up 0.01% of Squarepoint's portfolio in Q2 2026, its #1562 holding.
  • Squarepoint first reported a position in Organon & Co in Q2 2021 and has held it in 19 quarters since.
  • Squarepoint's Organon & Co position peaked at $20.8M in Q4 2023.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.